With more-advanced renal failure, phosphate binders become necessary to maintain phosphate balance and to prevent hyperphosphatemia. Because of toxicity, aluminum-containing phosphate binders are ...

New Drug Application for hyperphosphatemia in chronic kidney disease patients on dialysis under review by the FDA with a ...

AJ Rice, UBS: Asked about patient care cost growth outside of phosphate binders. Ackerman noted a 3.75% anticipated growth in historical costs, primarily from labor and other expenses. Pito ...

on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH offers a different mechanism ...

Try Now>> See today’s best-performing stocks on TipRanks Unicycive Therapeutics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The panel also voted by 10 to two, with one abstention, that it is safe to use in combination with conventional phosphate binder drugs, the only approved therapy for hyperphosphataemia.

Owing to its novel mechanism of action, tenapanor can be used in combination with phosphate binders to further significantly reduce serum phosphate levels and improve the rate of achieving target ...

OPTIMIZE was a randomized, open label study, which included 330 patients with chronic kidney disease (CKD) on dialysis with hyperphosphatemia. The study was designed to evaluate different methods of ...